Tapewire

Nasdaq · USD

CTMX

CytomX Therapeutics, Inc.

Export transactions ↓
Tapewire entity
5124
SEC CIK
0001501989
Parsed reports
342

Last 12 months

Inside the activity.

0 purchase rows · 6 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202600
Feb 202600
Mar 202604
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 27, 2017 Filed Mar 27, 2017 19:28 UTC
TRV GP, LLC10% owner
Levin Mark J10% owner
STARR KEVIN P10% owner
SaleCommon Stock 650,000 $18.00 $11,700,195.00
Disclosure

SEC source: 0000899243-17-008731 · doc4.xml · nonDerivative · entry 2

THIRD ROCK VENTURES LP · CIK 0001408591 · 10% owner

Third Rock Ventures GP, L.P. · CIK 0001578976 · 10% owner

TRV GP, LLC · CIK 0001578973 · 10% owner

LEVIN MARK J · CIK 0001180428 · 10% owner

STARR KEVIN P · CIK 0001192603 · 10% owner

TEPPER ROBERT I · CIK 0001192595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,170,348

F2 · price: This price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.45, inclusive. Each of the reporting persons undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).

F1 · ownership.direct: These shares are directly held by Third Rock Ventures, L.P. ("TRV"). The general partner of TRV is Third Rock Ventures GP, L.P. ("TRV GP"). The general partner of TRV GP is TRV GP, LLC ("TRV GP LLC"). The individual managers of TRV GP LLC are Mark Levin ("Levin"), Kevin Starr ("Starr") and Dr. Robert Tepper ("Tepper"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.

Read SEC document
March 27, 2017 Filed Mar 27, 2017 19:25 UTC
Exter NeilDirector
SaleCommon Stock 0 $0.00 $0.00
Disclosure

SEC source: 0000899243-17-008729 · doc4.xml · nonDerivative · entry 2

Exter Neil · CIK 0001620014 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

F4 · shares: On March 27, 2017, TRV sold 650,000 shares of Common Stock of the Issuer. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.45, inclusive, and at a weighted average price of $18.0003. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4).

F4 · price: On March 27, 2017, TRV sold 650,000 shares of Common Stock of the Issuer. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.45, inclusive, and at a weighted average price of $18.0003. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4).

F5 · balance_after: After the transaction referenced in note (4), TRV owned 5,170,348 shares of Common Stock of the Issuer.

F3 · ownership.nature: The reporting person is a partner of Third Rock Ventures GP, L.P., which is the general partner of TRV. The reporting person disclaims beneficial ownership over the shares held by TRV, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares.

Read SEC document
March 27, 2017 Filed Mar 28, 2017 17:36 UTC OtherCommon Stock 750,000 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-17-008751 · doc4.xml · nonDerivative · entry 1

Canaan IX L.P. · CIK 0001538676 · Director

Canaan Partners IX LLC · CIK 0001654586 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,494,381

F1 · kind: On March 27, 2017, Canaan IX L.P. (the "Canaan Fund") distributed, for no consideration, 750,000 shares of Common Stock of the issuer (the "Shares") to its limited partners and to Canaan Partners IX LLC ("Canaan IX" and, together with the Canaan Fund, the "Canaan Entities"), the general partner of the Canaan Fund, representing each such partner's pro rata interest in the shares held by the Canaan Fund. On the same date, Canaan IX distributed, for no consideration, the Shares it received from the distribution to its members in an amount equal to each such member's pro rata interest in the Shares. The aforementioned distributions were made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended.

F1 · price: On March 27, 2017, Canaan IX L.P. (the "Canaan Fund") distributed, for no consideration, 750,000 shares of Common Stock of the issuer (the "Shares") to its limited partners and to Canaan Partners IX LLC ("Canaan IX" and, together with the Canaan Fund, the "Canaan Entities"), the general partner of the Canaan Fund, representing each such partner's pro rata interest in the shares held by the Canaan Fund. On the same date, Canaan IX distributed, for no consideration, the Shares it received from the distribution to its members in an amount equal to each such member's pro rata interest in the Shares. The aforementioned distributions were made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended.

F2 · ownership.nature: The shares are held directly by the Canaan Fund. Canaan IX, is the sole general partner of the Canaan Fund, and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. Timothy Shannon, a non-managing member of Canaan IX, serves as representative of the Canaan Entities on the issuer's board of directors. Canaan IX disclaims Section 16 beneficial ownership of the securities held by the Canaan Fund, except to the extent of its pecuniary interest therein, if any.

Read SEC document
March 23, 2017 Filed Mar 27, 2017 19:28 UTC
TRV GP, LLC10% owner
Levin Mark J10% owner
STARR KEVIN P10% owner
SaleCommon Stock 1,000,000 $17.00 $17,000,200.00
Disclosure

SEC source: 0000899243-17-008731 · doc4.xml · nonDerivative · entry 1

THIRD ROCK VENTURES LP · CIK 0001408591 · 10% owner

Third Rock Ventures GP, L.P. · CIK 0001578976 · 10% owner

TRV GP, LLC · CIK 0001578973 · 10% owner

LEVIN MARK J · CIK 0001180428 · 10% owner

STARR KEVIN P · CIK 0001192603 · 10% owner

TEPPER ROBERT I · CIK 0001192595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,820,348

F1 · ownership.direct: These shares are directly held by Third Rock Ventures, L.P. ("TRV"). The general partner of TRV is Third Rock Ventures GP, L.P. ("TRV GP"). The general partner of TRV GP is TRV GP, LLC ("TRV GP LLC"). The individual managers of TRV GP LLC are Mark Levin ("Levin"), Kevin Starr ("Starr") and Dr. Robert Tepper ("Tepper"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.

Read SEC document
March 23, 2017 Filed Mar 27, 2017 19:25 UTC
Exter NeilDirector
SaleCommon Stock 0 $0.00 $0.00
Disclosure

SEC source: 0000899243-17-008729 · doc4.xml · nonDerivative · entry 1

Exter Neil · CIK 0001620014 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

F1 · shares: On March 23, 2017, Third Rock Ventures, L.P. ("TRV") sold 1,000,000 shares of Common Stock of the Issuer. The shares were sold in one execution at a price per share of $17.0002.

F1 · price: On March 23, 2017, Third Rock Ventures, L.P. ("TRV") sold 1,000,000 shares of Common Stock of the Issuer. The shares were sold in one execution at a price per share of $17.0002.

F2 · balance_after: After the transaction referenced in note (1), TRV owned 5,820,348 shares of Common Stock of the Issuer.

F3 · ownership.nature: The reporting person is a partner of Third Rock Ventures GP, L.P., which is the general partner of TRV. The reporting person disclaims beneficial ownership over the shares held by TRV, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares.

Read SEC document
March 20, 2017 Filed Mar 21, 2017 22:05 UTC
Goeltz II Robert C.Chief Financial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 21,517 $0.00 Strike: $4.47 $0.00
Disclosure

SEC source: 0001140361-17-012870 · doc1.xml · derivative · entry 4

Goeltz II Robert C. · CIK 0001653881 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 217,658

Underlying: Common Stock · 21,517 shares

Expires 2025-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option vests 25% on May 4, 2016, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, with each additional installment vesting on the last day of the month, except the final installment, which shall vest on May 4, 2019.

Read SEC document
March 20, 2017 Filed Mar 21, 2017 22:05 UTC
Goeltz II Robert C.Chief Financial Officer
SaleCommon Stock 11,517 $20.00 $230,340.00
Disclosure

SEC source: 0001140361-17-012870 · doc1.xml · nonDerivative · entry 3

Goeltz II Robert C. · CIK 0001653881 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,789

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

Read SEC document
March 20, 2017 Filed Mar 21, 2017 22:05 UTC
Goeltz II Robert C.Chief Financial Officer
SaleCommon Stock 10,000 $19.60 $196,000.00
Disclosure

SEC source: 0001140361-17-012870 · doc1.xml · nonDerivative · entry 2

Goeltz II Robert C. · CIK 0001653881 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,306

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

Read SEC document
March 20, 2017 Filed Mar 21, 2017 22:05 UTC
Goeltz II Robert C.Chief Financial Officer
Exercise / conversionCommon Stock 21,517 $4.47 $96,241.24
Disclosure

SEC source: 0001140361-17-012870 · doc1.xml · nonDerivative · entry 1

Goeltz II Robert C. · CIK 0001653881 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,306

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 20, 2017 Filed Mar 21, 2017 22:04 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 14,343 $0.00 Strike: $0.95 $0.00
Disclosure

SEC source: 0001140361-17-012869 · doc1.xml · derivative · entry 4

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,415

Underlying: Common Stock · 14,343 shares

Expires 2023-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable.

Read SEC document
March 20, 2017 Filed Mar 21, 2017 22:04 UTC
McCarthy Sean A.Director · President and CEO
SaleCommon Stock 14,343 $19.60 $281,122.80
Disclosure

SEC source: 0001140361-17-012869 · doc1.xml · nonDerivative · entry 2

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,979

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

Read SEC document
March 20, 2017 Filed Mar 21, 2017 22:04 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionCommon Stock 14,343 $0.95 $13,554.14
Disclosure

SEC source: 0001140361-17-012869 · doc1.xml · nonDerivative · entry 1

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,322

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 15, 2017 Filed Mar 16, 2017 17:30 UTC
TRV GP, LLC10% owner
Levin Mark J10% owner
STARR KEVIN P10% owner
OtherCommon Stock 850,000 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-17-007785 · doc4.xml · nonDerivative · entry 1

THIRD ROCK VENTURES LP · CIK 0001408591 · 10% owner

Third Rock Ventures GP, L.P. · CIK 0001578976 · 10% owner

TRV GP, LLC · CIK 0001578973 · 10% owner

LEVIN MARK J · CIK 0001180428 · 10% owner

STARR KEVIN P · CIK 0001192603 · 10% owner

TEPPER ROBERT I · CIK 0001192595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,820,348

F1 · kind: Pursuant to a Rule 10b5-1 trading plan adopted by Third Rock Ventures, L.P. ("TRV"), TRV distributed on March 15, 2017, for no consideration, 850,000 shares of Common Stock of the Issuer (the "Shares") to its limited partners and to Third Rock Ventures GP, L.P. ("TRV GP"), the general partner of TRV, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP distributed, for no consideration, the Shares it received in the distribution by TRV to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended.

F1 · price: Pursuant to a Rule 10b5-1 trading plan adopted by Third Rock Ventures, L.P. ("TRV"), TRV distributed on March 15, 2017, for no consideration, 850,000 shares of Common Stock of the Issuer (the "Shares") to its limited partners and to Third Rock Ventures GP, L.P. ("TRV GP"), the general partner of TRV, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP distributed, for no consideration, the Shares it received in the distribution by TRV to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended.

F2 · ownership.direct: These shares are directly held by TRV. The general partner of TRV is TRV GP. The general partner of TRV GP is TRV GP, LLC ("TRV GP LLC"). The individual managers of TRV GP LLC are Mark Levin ("Levin"), Kevin Starr ("Starr") and Dr. Robert Tepper ("Tepper"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.

Read SEC document
March 09, 2017 Filed Mar 10, 2017 00:22 UTC
Goeltz II Robert C.Chief Financial Officer
Exercise / conversionStock Option (right to buy) · Derivative 2,500 $0.00 Strike: $4.47 $0.00
Disclosure

SEC source: 0001140361-17-011297 · doc1.xml · derivative · entry 2

Goeltz II Robert C. · CIK 0001653881 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 239,175

Underlying: Common Stock · 2,500 shares

Expires 2025-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: This option vests 25% on May 4, 2016, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, with each additional installment vesting on the last day of the month, except the final installment, which shall vest on May 4, 2019.

Read SEC document
March 09, 2017 Filed Mar 10, 2017 00:22 UTC
Goeltz II Robert C.Chief Financial Officer
Exercise / conversionCommon Stock 2,500 $4.47 $11,182.00
Disclosure

SEC source: 0001140361-17-011297 · doc1.xml · nonDerivative · entry 1

Goeltz II Robert C. · CIK 0001653881 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,789

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 03, 2017 Filed Mar 3, 2017 22:36 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 14,343 $0.00 Strike: $1.13 $0.00
Disclosure

SEC source: 0001140361-17-010608 · doc1.xml · derivative · entry 4

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 366,961

Underlying: Common Stock · 14,343 shares

Expires 2021-09-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable.

Read SEC document
March 03, 2017 Filed Mar 3, 2017 22:36 UTC
McCarthy Sean A.Director · President and CEO
SaleCommon Stock 14,343 $15.00 $215,145.00
Disclosure

SEC source: 0001140361-17-010608 · doc1.xml · nonDerivative · entry 2

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,979

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

Read SEC document
March 03, 2017 Filed Mar 3, 2017 22:36 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionCommon Stock 14,343 $1.13 $16,263.53
Disclosure

SEC source: 0001140361-17-010608 · doc1.xml · nonDerivative · entry 1

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,322

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 25, 2017 Filed Jan 27, 2017 13:52 UTC
LADD CYNTHIA JSenior VP and General Counsel
GrantStock Option (right to buy) · Derivative 84,000 $0.00 Strike: $11.94 $0.00
Disclosure

SEC source: 0001140361-17-003157 · doc1.xml · derivative · entry 1

LADD CYNTHIA J · CIK 0001217596 · Senior VP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,000

Underlying: Common Stock · 84,000 shares

Expires 2027-01-24

F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2017 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.

Read SEC document
January 25, 2017 Filed Jan 27, 2017 18:54 UTC
McCarthy Sean A.Director · President and CEO
GrantStock Option (right to buy) · Derivative 310,000 $0.00 Strike: $11.94 $0.00
Disclosure

SEC source: 0001140361-17-003160 · doc1.xml · derivative · entry 1

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 310,000

Underlying: Common Stock · 310,000 shares

Expires 2027-01-24

F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2017 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.

Read SEC document
January 25, 2017 Filed Jan 27, 2017 18:54 UTC
HUMPHREY RACHELChief Medical Officer
GrantStock Option (right to buy) · Derivative 120,000 $0.00 Strike: $11.94 $0.00
Disclosure

SEC source: 0001140361-17-003159 · doc1.xml · derivative · entry 1

HUMPHREY RACHEL · CIK 0001579781 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2027-01-24

F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2017 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.

Read SEC document
January 25, 2017 Filed Jan 27, 2017 18:53 UTC
Kavanaugh William MichaelCSO, Head Res.&Non-Clin. Dev.
GrantStock Option (right to buy) · Derivative 120,000 $0.00 Strike: $11.94 $0.00
Disclosure

SEC source: 0001140361-17-003158 · doc1.xml · derivative · entry 1

Kavanaugh William Michael · CIK 0001578767 · CSO, Head Res.&Non-Clin. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires 2027-01-24

F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2017 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.

Read SEC document
January 25, 2017 Filed Jan 27, 2017 18:51 UTC
Goeltz II Robert C.Chief Financial Officer
GrantStock Option (right to buy) · Derivative 84,000 $0.00 Strike: $11.94 $0.00
Disclosure

SEC source: 0001140361-17-003155 · doc1.xml · derivative · entry 1

Goeltz II Robert C. · CIK 0001653881 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,000

Underlying: Common Stock · 84,000 shares

Expires 2027-01-24

F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2017 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.

Read SEC document
December 28, 2016 Filed Dec 29, 2016 20:52 UTC
HUMPHREY RACHELChief Medical Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 15,117 $0.00 Strike: $6.61 $0.00
Disclosure

SEC source: 0001140361-16-091061 · doc1.xml · derivative · entry 2

HUMPHREY RACHEL · CIK 0001579781 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 278,097

Underlying: Common Stock · 15,117 shares

Expires 2025-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: This option vests 25% on August 28, 2016, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, with each additional installment vesting on the last day of the month, except the final installment, which shall vest on August 28, 2019.

Read SEC document
December 28, 2016 Filed Dec 29, 2016 20:52 UTC
HUMPHREY RACHELChief Medical Officer
Exercise / conversionCommon Stock 15,117 $6.61 $99,994.42
Disclosure

SEC source: 0001140361-16-091061 · doc1.xml · nonDerivative · entry 1

HUMPHREY RACHEL · CIK 0001579781 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,117

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 30, 2016 Filed Dec 2, 2016 00:02 UTC
McCarthy Sean A.Director · President and CEO
GrantCommon Stock 1,979 $9.10 $17,999.01
Disclosure

SEC source: 0001140361-16-088448 · doc1.xml · nonDerivative · entry 1

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,979

F1 · kind: 1,979 shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
November 30, 2016 Filed Dec 1, 2016 19:27 UTC OtherCommon Stock 400,000 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-16-034627 · doc4.xml · nonDerivative · entry 2

Canaan IX L.P. · CIK 0001538676 · Director

Canaan Partners IX LLC · CIK 0001654586 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,244,381

F3 · kind: On November 30, 2016, the Canaan Fund distributed, for no consideration, 400,000 shares of Common Stock of the issuer (the "Shares") to its limited partners and to Canaan IX, its general partner, representing each such partner's pro rata interest in the shares held by the Canaan Fund. On the same date, Canaan IX distributed, for no consideration, the Shares it received from the distribution to its members in an amount equal to each such member's pro rata interest in the Shares. The aforementioned distributions were made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended.

F3 · price: On November 30, 2016, the Canaan Fund distributed, for no consideration, 400,000 shares of Common Stock of the issuer (the "Shares") to its limited partners and to Canaan IX, its general partner, representing each such partner's pro rata interest in the shares held by the Canaan Fund. On the same date, Canaan IX distributed, for no consideration, the Shares it received from the distribution to its members in an amount equal to each such member's pro rata interest in the Shares. The aforementioned distributions were made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended.

F2 · ownership.nature: The shares are held directly by Canaan IX L.P. (the "Canaan Fund"). Canaan Partners IX LLC ("Canaan IX" and together with the Canaan Fund, the "Canaan Entities") is the sole general partner of the Canaan Fund, and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. Timothy Shannon, a non-managing member of Canaan IX, serves as representative of the Canaan Entities on the issuer's board of directors. Canaan IX disclaims Section 16 beneficial ownership of the securities held by the Canaan Fund, except to the extent of its pecuniary interest therein, if any.

Read SEC document
November 30, 2016 Filed Dec 2, 2016 00:01 UTC
Goeltz II Robert C.Chief Financial Officer
GrantCommon Stock 1,289 $9.10 $11,723.46
Disclosure

SEC source: 0001140361-16-088447 · doc1.xml · nonDerivative · entry 1

Goeltz II Robert C. · CIK 0001653881 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,289

F1 · kind: 1,289 shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
November 29, 2016 Filed Dec 1, 2016 14:35 UTC SaleCommon Stock 22,086 $11.18 $247,007.62
Disclosure

SEC source: 0001140361-16-088355 · doc1.xml · nonDerivative · entry 1

SHANNON TIMOTHY M · CIK 0001207114 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,244,381

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.06 - $11.37, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
November 29, 2016 Filed Dec 1, 2016 19:27 UTC SaleCommon Stock 22,086 $11.18 $247,007.62
Disclosure

SEC source: 0000899243-16-034627 · doc4.xml · nonDerivative · entry 1

Canaan IX L.P. · CIK 0001538676 · Director

Canaan Partners IX LLC · CIK 0001654586 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,644,381

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.06 - $11.37, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) of this Form 4.

F2 · ownership.nature: The shares are held directly by Canaan IX L.P. (the "Canaan Fund"). Canaan Partners IX LLC ("Canaan IX" and together with the Canaan Fund, the "Canaan Entities") is the sole general partner of the Canaan Fund, and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. Timothy Shannon, a non-managing member of Canaan IX, serves as representative of the Canaan Entities on the issuer's board of directors. Canaan IX disclaims Section 16 beneficial ownership of the securities held by the Canaan Fund, except to the extent of its pecuniary interest therein, if any.

Read SEC document
November 28, 2016 Filed Nov 28, 2016 17:50 UTC SaleCommon Stock 20,840 $11.33 $236,142.21
Disclosure

SEC source: 0001140361-16-087978 · doc1.xml · nonDerivative · entry 3

SHANNON TIMOTHY M · CIK 0001207114 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,666,467

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.11 - $11.69 inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
November 28, 2016 Filed Nov 28, 2016 22:10 UTC
Canaan IX L.P.Director · 10% owner
Canaan Partners IX LLCDirector · 10% owner
SaleCommon Stock 20,840 $11.33 $236,142.21
Disclosure

SEC source: 0000899243-16-034442 · doc4.xml · nonDerivative · entry 3

Canaan IX L.P. · CIK 0001538676 · Director · 10% owner

Canaan Partners IX LLC · CIK 0001654586 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,666,467

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.11 - $11.69, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) of this Form 4.

F2 · ownership.nature: The shares are held directly by Canaan IX L.P. (the "Canaan Fund"). Canaan Partners IX LLC ("Canaan IX" and together with the Canaan Fund, the "Canaan Entities") is the sole general partner of the Canaan Fund, and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. Timothy Shannon, a non-managing member of Canaan IX, serves as representative of the Canaan Entities on the issuer's board of directors. Canaan IX disclaims Section 16 beneficial ownership of the securities held by the Canaan Fund, except to the extent of its pecuniary interest therein, if any.

Read SEC document
November 25, 2016 Filed Nov 28, 2016 17:50 UTC SaleCommon Stock 6,729 $11.79 $79,340.97
Disclosure

SEC source: 0001140361-16-087978 · doc1.xml · nonDerivative · entry 2

SHANNON TIMOTHY M · CIK 0001207114 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,687,307

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.67 - $12.07 inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
November 25, 2016 Filed Nov 28, 2016 22:10 UTC
Canaan IX L.P.Director · 10% owner
Canaan Partners IX LLCDirector · 10% owner
SaleCommon Stock 6,729 $11.79 $79,340.97
Disclosure

SEC source: 0000899243-16-034442 · doc4.xml · nonDerivative · entry 2

Canaan IX L.P. · CIK 0001538676 · Director · 10% owner

Canaan Partners IX LLC · CIK 0001654586 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,687,307

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.67 - $12.07, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) of this Form 4.

F2 · ownership.nature: The shares are held directly by Canaan IX L.P. (the "Canaan Fund"). Canaan Partners IX LLC ("Canaan IX" and together with the Canaan Fund, the "Canaan Entities") is the sole general partner of the Canaan Fund, and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. Timothy Shannon, a non-managing member of Canaan IX, serves as representative of the Canaan Entities on the issuer's board of directors. Canaan IX disclaims Section 16 beneficial ownership of the securities held by the Canaan Fund, except to the extent of its pecuniary interest therein, if any.

Read SEC document
November 23, 2016 Filed Nov 28, 2016 17:50 UTC SaleCommon Stock 10,890 $11.84 $128,921.27
Disclosure

SEC source: 0001140361-16-087978 · doc1.xml · nonDerivative · entry 1

SHANNON TIMOTHY M · CIK 0001207114 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,694,036

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.3950 - $12.05, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
November 23, 2016 Filed Nov 28, 2016 22:10 UTC
Canaan IX L.P.Director · 10% owner
Canaan Partners IX LLCDirector · 10% owner
SaleCommon Stock 10,890 $11.84 $128,921.27
Disclosure

SEC source: 0000899243-16-034442 · doc4.xml · nonDerivative · entry 1

Canaan IX L.P. · CIK 0001538676 · Director · 10% owner

Canaan Partners IX LLC · CIK 0001654586 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,694,036

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.3950 - $12.05, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) of this Form 4.

F2 · ownership.nature: The shares are held directly by Canaan IX L.P. (the "Canaan Fund"). Canaan Partners IX LLC ("Canaan IX" and together with the Canaan Fund, the "Canaan Entities") is the sole general partner of the Canaan Fund, and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. Timothy Shannon, a non-managing member of Canaan IX, serves as representative of the Canaan Entities on the issuer's board of directors. Canaan IX disclaims Section 16 beneficial ownership of the securities held by the Canaan Fund, except to the extent of its pecuniary interest therein, if any.

Read SEC document
November 22, 2016 Filed Nov 22, 2016 19:01 UTC SaleCommon Stock 42,550 $11.71 $498,077.54
Disclosure

SEC source: 0001140361-16-087649 · doc1.xml · nonDerivative · entry 1

SHANNON TIMOTHY M · CIK 0001207114 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,704,926

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.56 - $11.90, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
November 22, 2016 Filed Nov 22, 2016 23:48 UTC
Canaan IX L.P.Director · 10% owner
Canaan Partners IX LLCDirector · 10% owner
SaleCommon Stock 42,550 $11.71 $498,077.54
Disclosure

SEC source: 0000899243-16-034194 · doc4.xml · nonDerivative · entry 1

Canaan IX L.P. · CIK 0001538676 · Director · 10% owner

Canaan Partners IX LLC · CIK 0001654586 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,704,926

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.56 - $11.90, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) of this Form 4.

F2 · ownership.nature: The shares are held directly by Canaan IX L.P. (the "Canaan Fund"). Canaan Partners IX LLC ("Canaan IX" and together with the Canaan Fund, the "Canaan Entities") is the sole general partner of the Canaan Fund, and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. Timothy Shannon, a non-managing member of Canaan IX, serves as representative of the Canaan Entities on the issuer's board of directors. Canaan IX disclaims Section 16 beneficial ownership of the securities held by the Canaan Fund, except to the extent of its pecuniary interest therein, if any.

Read SEC document
November 21, 2016 Filed Nov 21, 2016 18:56 UTC SaleCommon Stock 13,548 $11.72 $158,785.27
Disclosure

SEC source: 0001140361-16-087469 · doc1.xml · nonDerivative · entry 3

SHANNON TIMOTHY M · CIK 0001207114 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,747,476

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.55 - $11.835, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
November 21, 2016 Filed Nov 21, 2016 23:48 UTC
Canaan IX L.P.Director · 10% owner
Canaan Partners IX LLCDirector · 10% owner
SaleCommon Stock 13,548 $11.72 $158,785.27
Disclosure

SEC source: 0000899243-16-034052 · doc4.xml · nonDerivative · entry 3

Canaan IX L.P. · CIK 0001538676 · Director · 10% owner

Canaan Partners IX LLC · CIK 0001654586 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,747,476

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.55 - $11.835, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) of this Form 4.

F2 · ownership.nature: The shares are held directly by Canaan IX L.P. (the "Canaan Fund"). Canaan Partners IX LLC ("Canaan IX" and together with the Canaan Fund, the "Canaan Entities") is the sole general partner of the Canaan Fund, and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. Timothy Shannon, a non-managing member of Canaan IX, serves as representative of the Canaan Entities on the issuer's board of directors. Canaan IX disclaims Section 16 beneficial ownership of the securities held by the Canaan Fund, except to the extent of its pecuniary interest therein, if any.

Read SEC document
November 18, 2016 Filed Nov 21, 2016 18:56 UTC SaleCommon Stock 12,805 $11.64 $149,084.77
Disclosure

SEC source: 0001140361-16-087469 · doc1.xml · nonDerivative · entry 2

SHANNON TIMOTHY M · CIK 0001207114 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,761,024

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.48 - $11.73, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
November 18, 2016 Filed Nov 21, 2016 23:48 UTC
Canaan IX L.P.Director · 10% owner
Canaan Partners IX LLCDirector · 10% owner
SaleCommon Stock 12,805 $11.64 $149,084.77
Disclosure

SEC source: 0000899243-16-034052 · doc4.xml · nonDerivative · entry 2

Canaan IX L.P. · CIK 0001538676 · Director · 10% owner

Canaan Partners IX LLC · CIK 0001654586 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,761,024

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.48 - $11.73, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) of this Form 4.

F2 · ownership.nature: The shares are held directly by Canaan IX L.P. (the "Canaan Fund"). Canaan Partners IX LLC ("Canaan IX" and together with the Canaan Fund, the "Canaan Entities") is the sole general partner of the Canaan Fund, and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. Timothy Shannon, a non-managing member of Canaan IX, serves as representative of the Canaan Entities on the issuer's board of directors. Canaan IX disclaims Section 16 beneficial ownership of the securities held by the Canaan Fund, except to the extent of its pecuniary interest therein, if any.

Read SEC document
November 17, 2016 Filed Nov 21, 2016 18:56 UTC SaleCommon Stock 18,971 $11.50 $218,217.72
Disclosure

SEC source: 0001140361-16-087469 · doc1.xml · nonDerivative · entry 1

SHANNON TIMOTHY M · CIK 0001207114 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,773,829

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.02 - $11.70, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
November 17, 2016 Filed Nov 21, 2016 23:48 UTC
Canaan IX L.P.Director · 10% owner
Canaan Partners IX LLCDirector · 10% owner
SaleCommon Stock 18,971 $11.50 $218,217.72
Disclosure

SEC source: 0000899243-16-034052 · doc4.xml · nonDerivative · entry 1

Canaan IX L.P. · CIK 0001538676 · Director · 10% owner

Canaan Partners IX LLC · CIK 0001654586 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,773,829

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.02 - $11.70, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) of this Form 4.

F2 · ownership.nature: The shares are held directly by Canaan IX L.P. (the "Canaan Fund"). Canaan Partners IX LLC ("Canaan IX" and together with the Canaan Fund, the "Canaan Entities") is the sole general partner of the Canaan Fund, and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. Timothy Shannon, a non-managing member of Canaan IX, serves as representative of the Canaan Entities on the issuer's board of directors. Canaan IX disclaims Section 16 beneficial ownership of the securities held by the Canaan Fund, except to the extent of its pecuniary interest therein, if any.

Read SEC document
November 16, 2016 Filed Nov 16, 2016 19:33 UTC SaleCommon Stock 18,517 $11.55 $213,952.82
Disclosure

SEC source: 0001140361-16-087008 · doc1.xml · nonDerivative · entry 2

SHANNON TIMOTHY M · CIK 0001207114 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,792,800

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.24 - $11.85, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
November 16, 2016 Filed Nov 17, 2016 00:13 UTC
Canaan IX L.P.Director · 10% owner
Canaan Partners IX LLCDirector · 10% owner
SaleCommon Stock 18,517 $11.55 $213,952.82
Disclosure

SEC source: 0000899243-16-033704 · doc4.xml · nonDerivative · entry 2

Canaan IX L.P. · CIK 0001538676 · Director · 10% owner

Canaan Partners IX LLC · CIK 0001654586 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,792,800

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.24 - $11.85, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) of this Form 4.

F2 · ownership.nature: The shares are held directly by Canaan IX L.P. (the "Canaan Fund"). Canaan Partners IX LLC ("Canaan IX" and together with the Canaan Fund, the "Canaan Entities") is the sole general partner of the Canaan Fund, and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. Timothy Shannon, a non-managing member of Canaan IX, serves as representative of the Canaan Entities on the issuer's board of directors. Canaan IX disclaims Section 16 beneficial ownership of the securities held by the Canaan Fund, except to the extent of its pecuniary interest therein, if any.

Read SEC document
November 15, 2016 Filed Nov 16, 2016 19:33 UTC SaleCommon Stock 33,064 $11.48 $379,475.53
Disclosure

SEC source: 0001140361-16-087008 · doc1.xml · nonDerivative · entry 1

SHANNON TIMOTHY M · CIK 0001207114 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,811,317

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.23 - $11.60, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
November 15, 2016 Filed Nov 17, 2016 00:13 UTC
Canaan IX L.P.Director · 10% owner
Canaan Partners IX LLCDirector · 10% owner
SaleCommon Stock 33,064 $11.48 $379,475.53
Disclosure

SEC source: 0000899243-16-033704 · doc4.xml · nonDerivative · entry 1

Canaan IX L.P. · CIK 0001538676 · Director · 10% owner

Canaan Partners IX LLC · CIK 0001654586 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,811,317

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.23 - $11.60, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) of this Form 4.

F2 · ownership.nature: The shares are held directly by Canaan IX L.P. (the "Canaan Fund"). Canaan Partners IX LLC ("Canaan IX" and together with the Canaan Fund, the "Canaan Entities") is the sole general partner of the Canaan Fund, and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. Timothy Shannon, a non-managing member of Canaan IX, serves as representative of the Canaan Entities on the issuer's board of directors. Canaan IX disclaims Section 16 beneficial ownership of the securities held by the Canaan Fund, except to the extent of its pecuniary interest therein, if any.

Read SEC document
November 14, 2016 Filed Nov 14, 2016 17:41 UTC SaleCommon Stock 23,744 $11.21 $266,056.27
Disclosure

SEC source: 0001140361-16-086602 · doc1.xml · nonDerivative · entry 3

SHANNON TIMOTHY M · CIK 0001207114 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 3,844,381

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.00 - $11.37, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The shares are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
November 14, 2016 Filed Nov 14, 2016 21:41 UTC
Canaan IX L.P.Director · 10% owner
Canaan Partners IX LLCDirector · 10% owner
SaleCommon Stock 23,744 $11.21 $266,056.27
Disclosure

SEC source: 0000899243-16-033335 · doc4.xml · nonDerivative · entry 3

Canaan IX L.P. · CIK 0001538676 · Director · 10% owner

Canaan Partners IX LLC · CIK 0001654586 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,844,381

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.00 - $11.37, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) of this Form 4.

F2 · ownership.nature: The shares are held directly by Canaan IX L.P. (the "Canaan Fund"). Canaan Partners IX LLC ("Canaan IX" and together with the Canaan Fund, the "Canaan Entities") is the sole general partner of the Canaan Fund, and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. Timothy Shannon, a non-managing member of Canaan IX, serves as representative of the Canaan Entities on the issuer's board of directors. Canaan IX disclaims Section 16 beneficial ownership of the securities held by the Canaan Fund, except to the extent of its pecuniary interest therein, if any.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.